Bird Flu > Bird Flu News > Biota ready to commercialise flu drug (The Age)
Biota ready to commercialise flu drug (The Age)
Anti-flu drug developer Biota Holdings says the way is open to commercialise its latest anti-flu compound, laninamivir, following successful late-stage trials.
Entire Avian Flu Pandemic Article - Avian Article Archives